Covid-19 BCG vaccine trial

04/05/20 PRESS RELEASE – immediate BCG Vaccine Clinical Trial in response to Covid-19 pandemic TASK008 – A placebo-controlled adaptive randomized controlled trial   Caption of press photo: TASK nurse injects the first participant, watched closely by study leader Dr Caryn Upton and Professor Andreas Diacon, founder and CEO of TASK.   TASK has just injected the…

Read more

New articles in the NEJM, Covid-19 & vaccine trials

While the world’s social media is inundated with populist commentary on the coronavirus, here is a tempered comment on what our appropriate response should be. https://www.nejm.org/doi/full/10.1056/NEJMp2003762?query=TOC #coronavirus #vaccines” Above article refers to Bill Gate’s position on Covid-19. In this he mentioned the importance of vaccines. A vaccine to interrupt the transmission of tuberculosis is also…

Read more

CAB Orientation on research and TB advocacy.

CAB invited a TB Advocate from TB Proof Mr Goodman Makanda to speak on “Being a TB Advocate and an Activist in the Community” The CAB discussed the relationship between Research and CAB, Looked into enhancing the CAB’s visibility in the Community and resources needed to execute their tasks effectively.

Read more

TASK Lab Tech presenting to the CAB

Recently one of TASK’s laboratory technologists presented a slide show on “the role of the laboratory in clinical research” to an enthusiastic audience of Community Advisory Board (CAB) members. The CAB where eager to learn and ask questions, this to relay information back to the communities in which they serve. This is their critical and primary…

Read more